Find More Contacts for Anixa Biosciences
Protected Content
CFO, COO, President
Non-Management, Executive Management, Operations
3 emails found 2 phone numbers found
View contacts for Anixa Biosciences to access new leads and connect with decision-makers.
View All Contacts
  • Phone Number 6315495974

Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which

uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's diagnostic portfolio consists of Cchek™, a liquid biopsy technology for early detection of solid tumors based on the body's immune response to the presence of a malignancy. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.

Lists Featuring This Company

United States Finance Companies (Top 10K)
9,955 Number of Organizations • $240.1B Total Funding Amount • 10,494 Number of Investors
United States Pharmaceutical Public Companies
420 Number of Organizations • $235.5B Total Funding Amount • 2,263 Number of Investors
United States Public Companies With Fewer Than 50 Employees
1,969 Number of Organizations • $84.6B Total Funding Amount • 2,369 Number of Investors
Greater New York Area Companies With Less Than $1B in Revenue (Top 10K)
9,852 Number of Organizations • $344.7B Total Funding Amount • 38,529 Number of Investors

Frequently Asked Questions

Where is Anixa Biosciences's headquarters? Anixa Biosciences is located in Melville, New York, United States.Who invested in Anixa Biosciences? Anixa Biosciences has 2 investors including U.S. Department of Defense and National Cancer Institute.How much funding has Anixa Biosciences raised to date? Anixa Biosciences has raised .When was the last funding round for Anixa Biosciences? Anixa Biosciences closed its last funding round on Dec 6, 2023 from a Grant round.Who are Anixa Biosciences's competitors? Alternatives and possible competitors to Anixa Biosciences may include Aclaris TherapeuticsInovio Pharmaceuticals, and Adamas Pharmaceuticals.